ESHRE 2026 in London – the most important findings for your treatment

From 5 to 8 July 2026, the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) took place in London – the world's most important congress for reproductive medicine. Over 8,000 experts discussed the latest research findings. Here we summarise the key insights for you.

Frozen transfer overtakes fresh IVF in Europe

Data from 36 European countries shows a clear trend: with 401,483 frozen transfer cycles, frozen embryo transfers have clearly overtaken fresh IVF cycles (158,649) for the first time. In total, over 1.15 million treatment cycles were carried out in Europe in 2023 – a new record. 247,021 children were born through assisted reproduction.

Source: European IVF Monitoring Consortium (EIM), preliminary data for the 2023 treatment year, presented at the 42nd Annual Meeting of ESHRE in London 2026.

68.2% cumulative live birth rate

One of the largest IVF studies analysed 18,396 women over three IVF cycles. The result: a cumulative live birth rate of 68.2% – with a multiple birth rate of only 2.9% thanks to consistent single embryo transfer. This shows: IVF is becoming ever safer and more successful.

Age and endometrium: new insights

A recent study shows that a woman's age has a direct impact on endometrial quality. While endometrial thickness remained similar across age groups, the proportion of women with an optimal trilaminar endometrium declined from 94.7% to 81.0%. This underlines the importance of individual endometrial assessment before embryo transfer.

What does this mean for you?

These findings feed directly into our treatment protocols. We always work according to the current state of science – from stimulation and embryo culture to transfer.